NSE Anchor Book Signals a New Balance in India’s Capital Markets

New Delhi [India], September 19: The National Stock Exchange’s ₹6,746 crore anchor book offers more than a snapshot of institutional demand for one of India’s most closely watched IPOs. It also provides a telling indication of how the balance of power within India’s investment banking ecosystem is evolving.

The most striking feature is the scale of domestic participation. Across the banking syndicate, domestic anchors accounted for approximately 51.4% of the total anchor mobilization, or around ₹3,464 crore. This puts domestic institutions marginally ahead of their international counterparts in the overall anchor mobilization.

The concentration becomes even more interesting when the leading bankers are examined in terms of the anchor investments they garnered. Five domestic merchant bankers, Kotak Mahindra Capital, SBICAPS, JM Financial, Axis Capital and Pantomath Capital, together brought in ₹3,261 crore, equivalent to about 48.3% of the entire ₹6,746 crore anchor book. Their combined mobilization was almost in the same range of ₹3,282 crore brought in by Morgan Stanley, Citi, HSBC and JP Morgan together. The composition of the domestic cohort is also telling, with established franchises such as Kotak Mahindra Capital, SBICAPS, JM Financial and Axis Capital appearing alongside a newer-generation banker, Pantomath Capital.

The numbers are significant because they illustrate how India’s domestic capital market infrastructure has deepened. Global investment banks continue to provide access to international long-only funds, sovereign wealth funds and other overseas institutions.

On the other hand, domestic merchant bankers now have access to a much broader institutional pool comprising mutual funds, insurers, pension funds and other domestic investors. A ₹3,261 crore mobilization by five Indian merchant bankers, virtually matching the combined contribution of four major global banks, suggests that the domestic ecosystem has acquired considerably greater depth and institutional reach.

The composition of the anchor book reinforces this trend. Domestic mutual funds received nearly 37% of the allocation, while foreign portfolio investors accounted for about 43%. LIC emerged as the largest individual anchor investor, while global institutions including Norway’s Government Pension Fund Global, the Monetary Authority of Singapore and Abu Dhabi Investment Authority also participated.

What makes the NSE transaction particularly interesting, therefore, is not a simple domestic-versus-foreign comparison. Rather, it demonstrates that India’s primary market is increasingly supported by two substantial pools of institutional capital. International banks retain significant global distribution capabilities, while Indian merchant bankers are increasingly able to mobilize sizeable domestic and institutional demand.

The NSE anchor book thus provides a useful marker of a broader transition: India’s primary market is no longer defined solely by the ability to tap global capital; it is increasingly underpinned by the scale, depth and growing sophistication of domestic institutional capital as well.

The National Stock Exchange of India (NSE) IPO continued its subscription process on September 19, with the issue already fully subscribed at 1.16 times by the end of Day 2, according to data available on the exchange’s website.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

9.5% stake due diligence fema Finance hemal mehta med therapy medtherapy biotechnology overseas investment sachin mehta sebi lodr sudarshan pharma

Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence

New Delhi [India], September 15: Sudarshan Pharma Industries Ltd has provided an update on its proposed acquisition of a 9.5% equity stake in US-based Med Therapy Biotechnology Inc., stating that the transaction is currently under due diligence. In a regulatory filing dated September 15, the company said the proposal to acquire the 9.5% stake in […]

Read More
Finance

How to Choose the Best Personal Loan for You

New Delhi [India], September 9: Availing a Personal Loan is perhaps the quickest way to meet your financial needs. They require minimal documentation, and you don’t need collateral. As long as you are eligible, the loan maybe approved and given to you almost instantly. TL;DR Choose a loan amount that meets your requirement without stretching […]

Read More
24/7 trading ai infrastructure broker cfd etf cfd Finance financial products leverage risk mt5 nuclear energy quantum computing Semiconductors stock cfd us stocks VT Markets

VT Markets Further Expands US Product Suite with 61 New Stock and ETF CFDs Spanning Quantum, Semiconductors, and NextGen Power

New Delhi [India], September 3: VT Markets, a leading global multi-asset broker, today announced the further expansion of its US product offering with the addition of over 60 new stock and ETF CFDs, fully tradable across MetaTrader 5 (MT5) and the VT Markets mobile app. Building on its ongoing product expansion strategy, the latest addition deepens trader access to the standout […]

Read More